Aztreonam/Avibactam (Emblaveo) for Complicated Intra-Abdominal Infections
Abstract
The FDA has approved Emblaveo (Abbvie), an intravenously administered fixed-dose combination of the monobactam antibacterial drug aztreonam and the beta-lactamase inhibitor avibactam, for use with metronidazole to treat complicated intra-abdominal infections (cIAIs) in adults.
Fields of Study & Subjects
Antibiotic Resistance in Bacteria
Antibiotics Pharmacokinetics and Efficacy
Antibiotic Use and Resistance
Publication details
- Journal / source
- The medical letter on drugs and therapeutics/The medical letter
- Volume
- 68
- Issue
- 1748
- Pages
- 25–27
- Publication date
- 6 February 2026
- Language
- EN